.
Cochlear Limited (ASX:COH) has recorded a fall in EBIT 54% for the first half of Fiscal 2014, falling from $108.3 million in H1 2013 to $49.4 million for H1 this year.
Net profit fell similar a percentage between the periods, from $77.7 million to $36.8 million.
The company said in an announcement that regulatory approval was still outstanding on a number of new products, slowing their release while also depressing sales of existing products.
Despite the regulatory difficulties, new lines of product were released in Q2 and sales improved 30% over Q1.
{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$318.62 |
Change
1.620(0.51%) |
Mkt cap ! $20.83B | |||
| Open | High | Low | Value | Volume |
| $317.80 | $319.13 | $315.50 | $11.51M | 36.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 10 | $318.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $318.62 | 4 | 4 |
View Market Depth
| Last trade - 13.47pm 29/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |